These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3502432

  • 1. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
    Hanaue H, Kim DY, Kubota M, Kurosawa T, Shikata J, Kondoh Y, Ogoshi K, Makuuchi H, Nakasaki H, Mitomi T.
    Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
    [Abstract] [Full Text] [Related]

  • 2. [The influence of a biological response modifier on thoracic lymphocytes--a study involving clinical cases and animal experiments].
    Hanaue H, Kurosawa T, Miyakawa S, Kitano Y, Nemoto A, Yamoto H, Asagoe T, Shikata J.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1285-9. PubMed ID: 3488025
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y, Ohgaki K, Tsuchitani T, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug 20; 24(8):1607-15. PubMed ID: 2809385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
    Mitachi Y, Murakawa Y, Okuno M, Kambe M, Kanamaru R, Takahasi H, Wakui A.
    Gan To Kagaku Ryoho; 1990 Mar 20; 17(3 Pt 2):482-8. PubMed ID: 2138871
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y, Torisu M.
    Surgery; 1990 Jan 20; 107(1):74-84. PubMed ID: 2404351
    [Abstract] [Full Text] [Related]

  • 10. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E, Toge T, Tanada M, Hamamoto S, Seto Y, Kohno H, Hattori T.
    Gan To Kagaku Ryoho; 1984 Jan 20; 11(1):123-9. PubMed ID: 6230053
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):799-811. PubMed ID: 2196311
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The effect of OK-432 in the treatment of primary lung cancer].
    Kishimoto T, Okada K.
    Gan To Kagaku Ryoho; 1987 Apr 20; 14(4):1051-6. PubMed ID: 3494430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T.
    Int J Oncol; 2004 Apr 20; 24(4):959-66. PubMed ID: 15010836
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.
    Mazumder A, Grimm EA, Rosenberg SA.
    J Immunol; 1983 Feb 20; 130(2):958-64. PubMed ID: 6848602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.